This protocol was submitted by the author(s) of the original paper via Bio-protocol's "Request a Protocol" feature.
Original Research Paper Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis
DOI: 10.1126/scitranslmed.aau8491
Science Translational Medicine , Feb 9, 2021
Related protocols in the same article
Procurement and treatment of human cartilage
Fadia Kamal    
Original Research Paper
Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis
Science Translational Medicine , Feb 9, 2021
DOI: 10.1126/scitranslmed.aau8491
Last updated date: Feb 22, 2021 View: 251
Download PDF How to cite Copy protocol link Q&A

How to cite: Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
1. Kamal, F. (2021). Procurement and treatment of human cartilage. Bio-protocol. bio-protocol.org/prep862.
2. Carlson, E., Karuppagounder, V., Pinamont, W., Yoshioka, N., Ahmad, A., Schott, E., Bleu, H., Zuscik, M., Elbarbary, R. and Kamal, F.(2021). Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis . Science Translational Medicine 13(580). DOI: 10.1126/scitranslmed.aau8491
Copyright: Content may be subjected to copyright.
 Q&A
Other Resources
www.bio-protocol.org
for advanced protocols
www.bio-thing.com
for reagents & equipment
lab.bio-thing.cn
for lab management
For Advertisers
Advertising Policy
Advertising Integrity Board
Advertising Terms and
Conditions
For Authors
Submission Procedure
Author guidelines
Submit a Protocol
About
About Us

Meet Our Ambassadors
©  Bio-protocol LLC. ISSN: 2331-8325 京ICP备11029730号-1 Terms of Service | Privacy Policy | Contact Us
Find out more
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.